Search research articles
Contact Us
Filters
Showing results (31-40 of 34) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 34 results.
Journal of Experimental & Clinical Cancer Research : CR
|
January 9, 2020
A pre-existing population of ZEB2<sup>+</sup> quiescent cells with stemness and mesenchymal features dictate chemoresistance in colorectal cancer
Federica Francescangeli, Paola Contavalli, Maria Laura De Angelis, et al.
Cancer Research
|
July 29, 2020
Pyrvinium Pamoate Induces Death of Triple-Negative Breast Cancer Stem-Like Cells and Reduces Metastases through Effects on Lipid Anabolism
Rosanna Dattilo, Carla Mottini, Emanuela Camera, et al.
Cell Death & Disease
|
July 24, 2019
A new bioavailable fenretinide formulation with antiproliferative, antimetabolic, and cytotoxic effects on solid tumors
Isabella Orienti, Federica Francescangeli, Maria Laura De Angelis, et al.
Nature Immunology
|
August 24, 2022
Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B
Martina Musella, Andrea Guarracino, Nicoletta Manduca, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 34) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 34 results.
Journal of Experimental & Clinical Cancer Research : CR
|
January 9, 2020
A pre-existing population of ZEB2<sup>+</sup> quiescent cells with stemness and mesenchymal features dictate chemoresistance in colorectal cancer
Federica Francescangeli, Paola Contavalli, Maria Laura De Angelis, et al.
Cancer Research
|
July 29, 2020
Pyrvinium Pamoate Induces Death of Triple-Negative Breast Cancer Stem-Like Cells and Reduces Metastases through Effects on Lipid Anabolism
Rosanna Dattilo, Carla Mottini, Emanuela Camera, et al.
Cell Death & Disease
|
July 24, 2019
A new bioavailable fenretinide formulation with antiproliferative, antimetabolic, and cytotoxic effects on solid tumors
Isabella Orienti, Federica Francescangeli, Maria Laura De Angelis, et al.
Nature Immunology
|
August 24, 2022
Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B
Martina Musella, Andrea Guarracino, Nicoletta Manduca, et al.
Page
of 4